Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer.

Surgery - 1 Mar 2006

Machens Andreas, Dralle Henning

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Carcinoma, Medullary
Share to Codon
Share to Germ-Line Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Selection

Share to Pedigree

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 16546489
DOI: 10.1016/j.surg.2005.07.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer.PMID 16546489Read ↗

Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapySemantic proximity Read ↗

Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial ManifestationsSemantic proximity Read ↗

Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities.Semantic proximity Read ↗

DNA methylation alterations as therapeutic prospects in thyroid cancerSemantic proximity Read ↗

Advances in the management of hereditary medullary thyroid cancer.Semantic proximity Read ↗

Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutationsSemantic proximity Read ↗

Genetic basis and gene therapy trials for thyroid cancer.Semantic proximity Read ↗

The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.Semantic proximity Read ↗

Moving towards the use of targeted therapies in thyroid cancer.Semantic proximity Read ↗

Emergence of Resistant Clones in Medullary Thyroid Cancer May Not Be Rescued by Subsequent Salvage Highly Selective Rearranged During Transfection-Inhibitor Therapy.Semantic proximity Read ↗

Biologic and Clinical Perspectives on Thyroid Cancer.Semantic proximity Read ↗

Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.